Treatment Action Group

CROI 2020 TB round up

Treatment Action Group (TAG) released an overview of TB data reported at the 2020 Conference on Retroviruses and Opportunistic Infections (CROI) virtually held on 8-11 March 2020. A summary of major findings, TAG’s take on them, and high-level summaries of select findings are available here.

Read More →

An Activist's Guide to the TB LAM Test

Treatment Action Group releases an updated version of its Activist’s Guide to the LAM Test with a complementary resource that tracks the status of LAM uptake in the 30 high TB/HIV burden countries.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs - webinar materials now available online

Treatment Action Group, Médecins Sans Frontières and Health GAP conducted a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

Webinar: What’s New—and Next—for TB Vaccines

Treatment Action Group (TAG) and AVAC will host a webinar on 6 February 2020 featuring an update on recent vaccine results and possible next steps with M72/AS01E, one of several new TB vaccine candidates.

Read More →

Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia

Activists urge Sanofi to do the same in other countries.

Read More →

Good COPs or Bad COPs webinar: Promoting interventions for co-infections and AIDS in 2020 PEPFAR COPs

Treatment Action Group, Médecins Sans Frontières and Health GAP will host a webinar on 22 January 2020 on how to engage in PEPFAR Country Operational Plans (COPs) advocacy and promote the prioritization of interventions that address HIV co-infections and AIDS.

Read More →

New TAG report: Funding for TB research climbed to new high in 2018

The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.

Read More →

TAG applauds Indian TB activists in opposing patents for critical TB prevention drugs

Civil society takes legal action to contest patent applications filed by Sanofi on fixed-dose combinations of two decades-old drugs used to prevent TB.

Read More →

TAG’s 2019 Pipeline Report: Three TB sections released

The sections provide an overview of TB diagnostics, vaccines and treatment.

Read More →

Public investments in TB medicine bedaquiline far exceed those of developer Johnson & Johnson

Quantification of investments in the development of bedaquiline finds total public and philanthropic expenditures are three to five times those of Johnson & Johnson.

Read More →

Page 1 of 15 · Total posts: 10

1 2 Last→